Prism Medico

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE730E01016
  • NSEID:
  • BSEID: 512217
INR
31.00
0.81 (2.68%)
BSENSE

May 21

BSE+NSE Vol: 9.64 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 701766,
    "name": "Prism Medico",
    "stock_name": "Prism Medico",
    "full_name": "Prism Medico & Pharmacy Ltd",
    "name_url": "stocks-analysis/prism-medico",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.00",
    "chg": 0.81,
    "chgp": "2.68%",
    "dir": 1,
    "prev_price": "30.19",
    "mcapval": "42.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512217,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE730E01016",
    "curr_date": "May 21",
    "curr_time": "",
    "bse_nse_vol": "9.64 k",
    "exc_status": "Active",
    "traded_date": "May 21, 2026",
    "traded_date_str": "2026 05 21",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/prism-medico-701766-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Prism Medico & Pharmacy Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/prism-medico-pharmacy-ltd-is-rated-sell-4002740",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PrismMedicoPhar_mojoScore_4002740.png",
        "date": "2026-05-21 10:10:42",
        "description": "Prism Medico & Pharmacy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Prism Medico & Pharmacy Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/prism-medico-pharmacy-ltd-is-rated-sell-3981421",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PrismMedicoPhar_mojoScore_3981421.png",
        "date": "2026-05-08 10:10:44",
        "description": "Prism Medico & Pharmacy Ltd is rated Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Prism Medico & Pharmacy Ltd Valuation Shifts Signal Price Attractiveness Change",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-valuation-shifts-signal-price-attractiveness-change-3976713",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PrismMedicoPhar_valuationdot_3976713.png",
        "date": "2026-05-06 08:00:30",
        "description": "Prism Medico & Pharmacy Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a subtle but meaningful change in price attractiveness. This reclassification comes amid mixed financial metrics and a volatile market backdrop, prompting investors to reassess the stock’s appeal relative to its peers and historical benchmarks."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 34.49",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-hits-new-52-week-high-at-rs3449-3967809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PrismMedicoPhar_priceRelatedfactors_3967809.png",
        "date": "2026-04-29 09:43:32",
        "description": "Surging past its previous peaks, Prism Medico & Pharmacy Ltd touched a new 52-week high of Rs 34.49 on 29 Apr 2026, marking a remarkable 128.87% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades cautiously below key moving averages."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 34",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-hits-new-52-week-high-at-rs34-3964632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PrismMedicoPhar_priceRelatedfactors_3964632.png",
        "date": "2026-04-27 14:37:25",
        "description": "With a remarkable 131.29% gain over the past year, Prism Medico & Pharmacy Ltd surged to a fresh 52-week high of Rs 34 on 27 Apr 2026, outpacing the Sensex which declined by 2.48% during the same period. This milestone caps a four-day winning streak that has propelled the stock up by 9.47%, underscoring a strong momentum that is supported by a confluence of technical indicators."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 33.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-hits-new-52-week-high-at-rs3365-3960367",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PrismMedicoPhar_priceRelatedfactors_3960367.png",
        "date": "2026-04-24 09:42:50",
        "description": "Surging past its previous peaks, Prism Medico & Pharmacy Ltd touched a fresh 52-week high of Rs 33.65 on 24 Apr 2026, marking a remarkable 126.56% gain over the past year. This rally stands in stark contrast to the broader market’s decline, with the Sensex down 3.48% over the same period, underscoring the stock’s strong momentum and technical resilience."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 33.58",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-hits-new-52-week-high-at-rs3358-3955528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PrismMedicoPhar_priceRelatedfactors_3955528.png",
        "date": "2026-04-21 09:42:35",
        "description": "With a decisive break above its previous peak, Prism Medico & Pharmacy Ltd surged to a new 52-week high of Rs 33.58 on 21 Apr 2026, marking a remarkable 107.4% gain over the past year. This milestone comes amid a sustained rally supported by a confluence of bullish technical indicators and a broader market environment that has been steadily advancing."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 32.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-hits-new-52-week-high-at-rs3215-3953544",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PrismMedicoPhar_priceRelatedfactors_3953544.png",
        "date": "2026-04-20 09:44:11",
        "description": "Surging past its previous peak, Prism Medico & Pharmacy Ltd touched a fresh 52-week high of Rs 32.15 on 20 Apr 2026, marking a remarkable doubling in price from its low of Rs 12.49 over the past year. This milestone reflects a sustained momentum driven by a confluence of bullish technical indicators and steady market participation."
      },
      {
        "title": "Prism Medico & Pharmacy Ltd Gains 6.83%: Valuation Shift and 52-Week High Mark the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-gains-683-valuation-shift-and-52-week-high-mark-the-week-3952501",
        "imagepath": "",
        "date": "2026-04-18 16:01:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> New 52-week high at Rs.31</p>\n                    <p><strong>15 Apr:</strong> Sharp 8.11% price surge on strong volume</p>\n                    <p><strong>16 Apr:</strong> Valuation shift to very expensive grade announced</p>\n                    <p><strong>17 Apr:</strong> Week closes at Rs.30.66, up 6.83% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.28.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.30.66</div><div class=\"stat-change positive\">+6..."
      }
    ],
    "total": 176,
    "sid": "701766",
    "stock_news_url": "https://www.marketsmojo.com/news/prism-medico-pharmacy-701766"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "11-May-2026",
      "details": "Dear Sir / Madam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 11th May 2026) which commenced at 04:00 P.M. and concluded at 04:30 P.M. have inter alia approved the following: 1. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates Chartered Accountants as internal auditors of the company for the financial year 2025-2026. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "05-May-2026",
      "details": "With reference to the subject cited this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday May 05 2026 at the registered office of the Company the following were considered and approved: 1. Allotment of 7500000 (Seventy Five Lacs) Equity Shares of face value of ?10/- each at an issue price of ?10/- (Rupees Ten Only) per Equity Share and 5000000 (Fifty Lacs) Convertible Warrants on a preferential basis at an issue price of ?10/- (Rupees Ten Only) per Warrant Convertible Warrants on Preferential Basis in accordance with and pursuant to the special resolution passed by the Members of the Company at their Extra-ordinary General Meeting held on March 20 2026 and In-Principle Approval received from BSE Ltd (Stock Exchange where the shares of the Company are listed) on March 25 2026. The details of the allottees have been enclosed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting For Allotment Of Securities",
      "datetime": "05-May-2026",
      "details": "With reference to the subject cited this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday May 05 2026 at the registered office of the Company the following were considered and approved: 1. Allotment of 7500000 (Seventy Five Lacs) Equity Shares of face value of ?10/- each at an issue price of ?10/- (Rupees Ten Only) per Equity Share and 5000000 (Fifty Lacs) Convertible Warrants on a preferential basis at an issue price of ?10/- (Rupees Ten Only) per Warrant Convertible Warrants on Preferential Basis in accordance with and pursuant to the special resolution passed by the Members of the Company at their Extra-ordinary General Meeting held on March 20 2026 and In-Principle Approval received from BSE Ltd (Stock Exchange where the shares of the Company are listed) on March 25 2026. The details of the allottees have been enclosed herewith.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

11-May-2026 | Source : BSE

Dear Sir / Madam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 11th May 2026) which commenced at 04:00 P.M. and concluded at 04:30 P.M. have inter alia approved the following: 1. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates Chartered Accountants as internal auditors of the company for the financial year 2025-2026. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.

Announcement under Regulation 30 (LODR)-Allotment

05-May-2026 | Source : BSE

With reference to the subject cited this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday May 05 2026 at the registered office of the Company the following were considered and approved: 1. Allotment of 7500000 (Seventy Five Lacs) Equity Shares of face value of ?10/- each at an issue price of ?10/- (Rupees Ten Only) per Equity Share and 5000000 (Fifty Lacs) Convertible Warrants on a preferential basis at an issue price of ?10/- (Rupees Ten Only) per Warrant Convertible Warrants on Preferential Basis in accordance with and pursuant to the special resolution passed by the Members of the Company at their Extra-ordinary General Meeting held on March 20 2026 and In-Principle Approval received from BSE Ltd (Stock Exchange where the shares of the Company are listed) on March 25 2026. The details of the allottees have been enclosed herewith.

Board Meeting Outcome for Outcome Of Board Meeting For Allotment Of Securities

05-May-2026 | Source : BSE

With reference to the subject cited this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday May 05 2026 at the registered office of the Company the following were considered and approved: 1. Allotment of 7500000 (Seventy Five Lacs) Equity Shares of face value of ?10/- each at an issue price of ?10/- (Rupees Ten Only) per Equity Share and 5000000 (Fifty Lacs) Convertible Warrants on a preferential basis at an issue price of ?10/- (Rupees Ten Only) per Warrant Convertible Warrants on Preferential Basis in accordance with and pursuant to the special resolution passed by the Members of the Company at their Extra-ordinary General Meeting held on March 20 2026 and In-Principle Approval received from BSE Ltd (Stock Exchange where the shares of the Company are listed) on March 25 2026. The details of the allottees have been enclosed herewith.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available